Skip to main content

Shared care prescribing and monitoring guidance

Within NHS Wales, shared care represents circumstances where primary care accept the transfer of prescribing responsibility from specialist care, for medicines that require long-term regular monitoring. The monitoring arrangements and responsibilities are set out in a formal shared care protocol for the specific treatment, and the patient continues to be followed-up in reviews by the specialist. This document updates the principles of best practice for shared care prescribing agreements.

Shared Care Prescribing and Monitoring Guidance 240KB (PDF)

(Published February 2021)

⇩ Generic Shared Care Template and Agreement Form 39KB (Word)

(Published February 2021)


Related documents:

⇩ Shared Care Template – Amiodarone 135KB (Word)

(Published May 2008)

⇩ Shared Care Template – Subcutaneous Methotrexate 270KB (Word)

(Published June 2009)

⇩ Information Note: Cystic Fibrosis Drugs – Interface Issues: Use of Tobramycin and Dornase Alfa for Adults with Cystic Fibrosis 12KB (PDF)

(Published April 2007)

⇩ Proposal to Update Near Patient Testing Enhanced Service 144KB (PDF)

(Published December 2010)

⇩ Shared Care Protocol – Denosumab 201KB (PDF)

(Published October 2013)

⇩ Definition of Shared Care 21KB (PDF)

(Published March 2006)

Follow AWTTC: